The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.
FDA Awards Research Grants for 18 Rare Diseases, Including HPV-Related Oropharyngeal Cancer
September 22nd 2015Eighteen new research grants, totaling more than $19 million, have been awarded by the FDA for product development in rare diseases such as HPV-related head and neck cancer and recurrent glioblastoma.
Slamon Explores Evolution of HER2-Positive Breast Cancer Treatment
September 21st 2015Dennis J. Slamon, MD, PhD, discusses the impact of the ADAPT and BOLERO trials and how the increased focus on neoadjuvant therapy with trastuzumab and T-DM1 could transform the treatment of HER2-positive breast cancer.
ABIM Poised to Scrap 10-Year MOC Requirements
September 17th 2015The American Board of Internal Medicine says it is working to incorporate a set of changes to its physician Certification and Maintenance of Certification requirements that physicians have complained are out of step with the realities of their work.
Birinapant May Reduce Chemoresistance, Recurrence in Certain Ovarian Cancers
September 13th 2015Sanaz Memarzadeh, MD, PhD, discusses a combination regimen of birinapant and carboplatin in patients with high-grade serous ovarian cancers and high levels of cellular inhibitor of apoptosis protein (cIAP) in their CA-125–negative cells.